Avior Wealth Management
HELP

Avior Wealth Management’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Avior Wealth Management’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6
Closed -$52 – 1110
2024
Q4 		$52 Buy
+6
New +$61 ﹤0.01% 2429

Other funds holding HELP

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Avior Wealth Management's HELP Position: Q1 2025 in Review

Avior Wealth Management sold out of Helus Pharma Inc. Common Stock (HELP) in Q1 2025, closing a stake of 6 shares — an estimated $52 sold.

Avior Wealth Management first reported a position in HELP in Q4 2024 and held it in 1 quarter. The position peaked at $52 in Q4 2024. 56 funds tracked by Wall St. Rank hold HELP as of Q1 2025.

  • Avior Wealth Management reported no remaining Helus Pharma Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Avior Wealth Management sold 6 Helus Pharma Inc. Common Stock shares in Q1 2025, an estimated $52.
  • Avior Wealth Management first reported a position in Helus Pharma Inc. Common Stock in Q4 2024 and held it in 1 quarter.
  • Avior Wealth Management's Helus Pharma Inc. Common Stock position peaked at $52 in Q4 2024.
  • 56 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q1 2025.

Based on Avior Wealth Management's 13F filing for Q1 2025, filed 21 Apr 2025.